Literature DB >> 28139356

Predictors of current functioning and functional decline in schizophrenia.

Jamie Joseph1, William S Kremen2, Carol E Franz1, Stephen J Glatt3, Joyce van de Leemput1, Sharon D Chandler1, Ming T Tsuang4, Elizabeth W Twamley5.   

Abstract

Positive, negative, and cognitive symptoms of schizophrenia may affect functional outcomes. However, these factors alone do not account for a large percentage of variance in outcomes. We investigated demographic, cognitive, symptom, and functional capacity predictors of current functional status in 280 outpatients with schizophrenia or schizoaffective disorder. Functional decline over the lifespan was also examined in a subset of participants. Stepwise regressions modeled predictors of current functional status and functional decline as measured by the Assessment of Lifespan Functioning Attainment (ALFA). ALFA functional domains included paid employment, independence in living situation, romantic relationships, close friendships, and recreational engagement. More severe depressive symptoms were consistently associated with worse current community integration (lower levels of close friendships and recreational engagement). Better working memory performance was associated with higher rates of current paid employment. There were no consistent modifiable predictors of decline in functioning, but women reported less functional decline in the domains of employment and close friendships than men. Better cognitive performance was associated with less decline in living independence and romantic relationships, but more decline in paid employment and recreational engagement. Increased assessment and treatment of comorbid depressive symptoms may improve functional outcomes in people with schizophrenia. Published by Elsevier B.V.

Entities:  

Keywords:  Cognition; Depression; Lifespan functioning; Psychosis

Mesh:

Year:  2017        PMID: 28139356      PMCID: PMC5529271          DOI: 10.1016/j.schres.2017.01.038

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  56 in total

1.  Schizophrenic syndromes and frontal lobe performance.

Authors:  P F Liddle; D L Morris
Journal:  Br J Psychiatry       Date:  1991-03       Impact factor: 9.319

2.  Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia.

Authors:  G Fervaha; G Foussias; O Agid; G Remington
Journal:  Acta Psychiatr Scand       Date:  2014-05-22       Impact factor: 6.392

3.  Self-report measures of schizotypy as indices of familial vulnerability to schizophrenia.

Authors:  K S Kendler; L Thacker; D Walsh
Journal:  Schizophr Bull       Date:  1996       Impact factor: 9.306

4.  Predictors of the accuracy of self assessment of everyday functioning in people with schizophrenia.

Authors:  Samir Sabbag; Elizabeth W Twamley; Lea Vella; Robert K Heaton; Thomas L Patterson; Philip D Harvey
Journal:  Schizophr Res       Date:  2012-03-02       Impact factor: 4.939

5.  Assessment of Lifespan Functioning Attainment (ALFA) scale: A quantitative interview for self-reported current and functional decline in schizophrenia.

Authors:  Jamie Joseph; William S Kremen; Stephen J Glatt; Carol E Franz; Sharon D Chandler; Xiaohua Liu; Barbara K Johnson; Ming T Tsuang; Elizabeth W Twamley
Journal:  J Psychiatr Res       Date:  2015-04-11       Impact factor: 4.791

6.  A depression rating scale for schizophrenics.

Authors:  D Addington; J Addington; B Schissel
Journal:  Schizophr Res       Date:  1990 Jul-Aug       Impact factor: 4.939

Review 7.  What do we know about neuropsychological aspects of schizophrenia?

Authors:  Barton W Palmer; Sharron E Dawes; Robert K Heaton
Journal:  Neuropsychol Rev       Date:  2009-07-30       Impact factor: 7.444

8.  Large recurrent microdeletions associated with schizophrenia.

Authors:  Hreinn Stefansson; Dan Rujescu; Sven Cichon; Olli P H Pietiläinen; Andres Ingason; Stacy Steinberg; Ragnheidur Fossdal; Engilbert Sigurdsson; Thordur Sigmundsson; Jacobine E Buizer-Voskamp; Thomas Hansen; Klaus D Jakobsen; Pierandrea Muglia; Clyde Francks; Paul M Matthews; Arnaldur Gylfason; Bjarni V Halldorsson; Daniel Gudbjartsson; Thorgeir E Thorgeirsson; Asgeir Sigurdsson; Adalbjorg Jonasdottir; Aslaug Jonasdottir; Asgeir Bjornsson; Sigurborg Mattiasdottir; Thorarinn Blondal; Magnus Haraldsson; Brynja B Magnusdottir; Ina Giegling; Hans-Jürgen Möller; Annette Hartmann; Kevin V Shianna; Dongliang Ge; Anna C Need; Caroline Crombie; Gillian Fraser; Nicholas Walker; Jouko Lonnqvist; Jaana Suvisaari; Annamarie Tuulio-Henriksson; Tiina Paunio; Timi Toulopoulou; Elvira Bramon; Marta Di Forti; Robin Murray; Mirella Ruggeri; Evangelos Vassos; Sarah Tosato; Muriel Walshe; Tao Li; Catalina Vasilescu; Thomas W Mühleisen; August G Wang; Henrik Ullum; Srdjan Djurovic; Ingrid Melle; Jes Olesen; Lambertus A Kiemeney; Barbara Franke; Chiara Sabatti; Nelson B Freimer; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Ole A Andreassen; Roel A Ophoff; Alexander Georgi; Marcella Rietschel; Thomas Werge; Hannes Petursson; David B Goldstein; Markus M Nöthen; Leena Peltonen; David A Collier; David St Clair; Kari Stefansson
Journal:  Nature       Date:  2008-09-11       Impact factor: 49.962

Review 9.  Functional role of adult hippocampal neurogenesis as a therapeutic strategy for mental disorders.

Authors:  Heechul Jun; Syed Mohammed Qasim Hussaini; Michael J Rigby; Mi-Hyeon Jang
Journal:  Neural Plast       Date:  2012-12-31       Impact factor: 3.599

10.  Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders.

Authors:  M T Ray; C Shannon Weickert; M J Webster
Journal:  Transl Psychiatry       Date:  2014-05-06       Impact factor: 6.222

View more
  5 in total

1.  Modifiable Predictors of Supported Employment Outcomes Among People With Severe Mental Illness.

Authors:  Zanjbeel Mahmood; Amber V Keller; Cynthia Z Burton; Lea Vella; Georg E Matt; Susan R McGurk; Elizabeth W Twamley
Journal:  Psychiatr Serv       Date:  2019-06-12       Impact factor: 3.084

2.  Abnormally Increased Secretion in Olfactory Neuronal Precursors from a Case of Schizophrenia Is Modulated by Melatonin: A Pilot Study.

Authors:  Montserrat G Cercós; Tania Galván-Arrieta; Marcela Valdés-Tovar; Héctor Solís-Chagoyán; Jesús Argueta; Gloria Benítez-King; Citlali Trueta
Journal:  Int J Mol Sci       Date:  2017-07-13       Impact factor: 5.923

3.  Key role for lipids in cognitive symptoms of schizophrenia.

Authors:  Dorien A Maas; Marijn B Martens; Nikos Priovoulos; Wieteke A Zuure; Judith R Homberg; Brahim Nait-Oumesmar; Gerard J M Martens
Journal:  Transl Psychiatry       Date:  2020-11-12       Impact factor: 6.222

Review 4.  Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia.

Authors:  Tanja Veselinović; Irene Neuner
Journal:  CNS Drugs       Date:  2022-07-13       Impact factor: 6.497

5.  How did that interaction make you feel? The relationship between quality of everyday social experiences and emotion in people with and without schizophrenia.

Authors:  Jasmine Mote; David E Gard; Rachel Gonzalez; Daniel Fulford
Journal:  PLoS One       Date:  2019-09-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.